يعرض 1 - 18 نتائج من 18 نتيجة بحث عن '"Disfunción miocárdica"', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
    Dissertation/ Thesis
  2. 2
    Academic Journal

    المصدر: Revista de Ecocardiografía Práctica y Otras Técnicas de Imagen Cardíaca; Vol. 6 No. 3 (2023): Journal of Practical Echocardiography and Other Cardiac Imaging Techniques; 54-57 ; Revista de Ecocardiografía Práctica y Otras Técnicas de Imagen Cardíaca; Vol. 6 Núm. 3 (2023): Revista de Ecocardiografía Práctica y Otras Técnicas de Imagen Cardíaca; 54-57 ; 2529-976X

    وصف الملف: application/pdf

  3. 3
    Academic Journal

    المساهمون: Hospital General Docente Enrique cabrera

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 28, No. 3 (2022): julio-septiembre; e1271 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 28, No. 3 (2022): julio-septiembre; e1271 ; 1561-2937

    وصف الملف: application/pdf

    Relation: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1271/pdf; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1271/1013; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1271/1014; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1271/1015; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1271/1016; Walley KR. Sepsis-induced myocardial dysfunction. Curr Opin Crit Care. 2018 [acceso 20/06/2021];24(4):3-6. Disponible en: https://pubmed.ncbi.nih.gov.; Narváeza I, Canabalb A, Martína C, Sánchez M, Moron A, Alcalá J, et al. Incidencia y evolución de la miocardiopatía séptica en una cohorte de pacientes con sepsis y shock séptico. Med Intensiva. 2018[acceso 20/06/2021];42(5):283-9. Disponible en: https://www.medintensiva.org/es-incidencia-evolución-miocardiopatía-septica-una-artículo-S0210569117302371.; Reverien H, Insu Ch, Hwa JCh, Dowan K, Kyoseon L, Inseok J. Sepsis-induced cardiac dysfunction: a review of pathophysiology. Acute and Critical Care. 2020 [acceso 20/06/2021];35(2):57-66. Disponible en: https://www.accjournal.org.; Quevedo Y, Pérez G, Abdo A, Quiles L, Hernández E, Leal G, et al. El corazón en la sepsis. Invest. Medicoquir 2020 [acceso 20/06/2021];12(2):1-3. Disponible en: https://www.revcimeq.sld.cu; Xiuxi L, Huadong W. Pathophysiology of sepsis-induced myocardial dysfunction. Military Medical Research. 2016 [acceso 20/06/2021];(3):1-9. Disponible en: https://link.springer.com/article/10.1186/s40779-016-0099-9; Ricarte-Bratti P, Brizuela Y, Urinovsky M, Moreyra E, Paredes S, Vogliotti I, et al. Valor pronóstico de la función ventricular evaluada mediante ecocardiografía con speckle tracking en pacientes con sepsis. Rev Insuf Card. 2017 [acceso 20/06/2021];12(1):9-15. Disponible en: https://www.insuficienciacardiaca.org.; Vallabhajosyula S, Wang Z, Murad H, Vallabhajosyula S, Sundaragiri P, Kashani K, et al. Natriuretic Peptides to Predict Short-Term Mortality in Patients With Sepsis: A Systematic Review and Meta-analysis. Mayo Clin Proc Innov Qual Outcomes. 2020 [acceso 20/06/2021];4(1):50-64. Disponible en: https://www.mcpiqojournal.org; Bono J, Barcudi R, Sarmiento P. Utilidad de las troponinas para el manejo del paciente crítico con enfermedad no cardíaca en la Unidad de Cuidados Intensivos. Revisión narrativa. RATI. 2020 [18/06/2021];37(3):43-57. Disponible en: http://revista.sati.org.ar.; Pérez G, Quevedo Y. Evaluación ecocardiográfica de la miocardiopatía séptica. Importancia de los biomarcadores. Invest. Medicoquir. 2021 [acceso 18/06/2021];13:1-18. Disponible en: http://revcimeq.sld.cu.; Mueller C, McDonald K, De Boer RA, Maisel A, Coats AJS, Metra M, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019 [acceso 18/06/2021];21(6):715-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov.; Villarroel-Ábrego H, Garrillo R, González-Suero J.C, Nuñez Ayala E. Correlación entre fracción de eyección del ventrículo izquierdo y strain longitudinal global en pacientes con hipertensión arterial. Rev Insuf Card. 2018 [acceso 18/06/2021];13(2):57-66. Disponible en: https://www.researchgate.net/publication/326198943-correlacion-fevi-vs-strain en-hta-revista-insuficiencia- cardiaca.; Rodríguez Y, Rugenio A, Sauza J, Franco J, Aguirre J, Camarena G. Asociación de mortalidad, deformación longitudinal global y circunferencial del ventrículo izquierdo en pacientes con sepsis en terapia intensiva. Med Crit. 2018 [acceso 18/06/2021];32(6):330-43. Disponible en: https://www.scielo.org.mx.; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1271

  4. 4

    المساهمون: Huertas Quiñones, Victor Manuel, Pedraza-Flechas, Ana María, Restrepo Martínez, Carlos

    المصدر: 1. De Angelis G, Bobbo M, Paldino A, D’Agata Mottolese B, Altinier A, Dal Ferro M, et al. Cardiomyopathies in children. Curr Opin Organ Transplant [Internet]. 2020Jun;25(3):218–30. Available from: http://journals.lww.com/10.1097/MOT.0000000000000755
    2. Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL, et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive estrategies and therapies. Future Cardiol [Internet]. 2013 Nov;9(6):817–48. Available from: https://www.futuremedicine.com/doi/abs/10.2217/fca.13.66
    3. Konta L, Franklin RCG, Kaski JP. Nomenclature and systems of classification for cardiomyopathy in children. Cardiol Young [Internet]. 2015 Aug 17;25(S2):31–42.Availablefrom:https://www.cambridge.org/core/product/identifier/S1047951115001201/type/journal_article
    4. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Heart [Internet]. 1980 Dec 1;44(6):672–3. Available from:http://heart.bmj.com/cgi/doi/10.1136/hrt.44.6.672
    5. Mathew J, Zahavich L, Lafreniere-Roula M, Wilson J, George K, Benson L, et al. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet[Internet]. 2018 Feb;93(2):310–9.Available from: http://doi.wiley.com/10.1111/cge.13157
    6. Ware SM. Cardiomyopathy in Children. J Am Coll Cardiol [Internet]. 2018Nov;72(19):2339–41. Available from:https://linkinghub.elsevier.com/retrieve/pii/S073510971838402X
    7. Huertas-Quiñones VM, Restrepo CM. Genética de las Cardiopatías Congénitas. Capítulo 15. Bloque 4-Genética del Corazón y sus estructuras. En López-Farré. Cardio-Genética. Primera ed. Sociedad Española de Cardiología, Universidad Complutense de Madrid. Editorial médica CTO. Madrid (España) 2015:175-202.ISBN 978-84-16153-91-6.
    8. Miocardiopatia dilatada [Internet]. 2018. Available from: https://healthincode.com/en/panels/cardiology/cardiomyopathy/dilated-cardiomyopathy/
    9. Huertas-Quiñones VM. Cardiomiopatías en edad pediátrica. En “Cardiología Pediátrica”. Díaz GF, Sandoval N, Vélez JF, ed. Segunda ed. Sociedad Colombiana de Cardiología. Editorial Distribuna. Bogotá (Colombia)2018:941-974. ISBN 978-958-8813-70-7.
    11. Monserrat L, Ochoa J, Garcia D, Ortiz M. Genética de la miocardiopatia hipertrofica. In: CTO E médica, editor. Cardio-genética. Primera ed. Madrid, España; 2015. p. 41–53.
    12. Levine GN. Restrictive Cardiomyopathy. In: Cardiology Secrets [Internet]. Elsevier;2010. p. 203–6. Available from: https://www.elsevier.com/books/cardiology-secrets/levine/978-0-323-47870-0
    13. Barredo M, Gonzalez J. Genética de la miocardiopatía restrictiva cardiaca. In: Cardiogenética. Primera edición. Madrid, España: Editorial médica CTO; 2015. p. 57–66.
    14. Sabaté Rotés A, Huertas-Quiñones VM, Betrián P, Carretero J, Jiménez L, Girona J, et al. Miocardiopatía no compactada: características clínicas, evolutivas y pronósticas en edad pediátrica. Resultados de un estudio multicéntrico. An Pediatr. 2012 Dec;77(6):360–5
    15. Miocardiopatia no compacta [Internet]. 2018. Available from:https://cardio.healthincode.com/genetica-cardiovascular/miocardiopatias/no-compactada
    16. Monserrat Iglesias L. Miocardiopatía no compactada: una enfermedad en busca de criterios. Rev Española Cardiol [Internet]. 2008 Feb;61(2):112–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0300893208733566
    17. Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, et al. Pediatric Cardiomyopathies. Circ Res [Internet]. 2017 Sep 15;121(7):855–73. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.116.309386
    18. Yuan S-M. Cardiomyopathy in the pediatric patients. Pediatr Neonatol [Internet]. 2018Apr;59(2):120–8. Available from: https://www.sciencedirect.com/science/article/pii/S1875957218300342
    19. Huertas-Quiñones VM, Mestra CF, Peña-Trujillo V, Gallo-Bernal S, Villaveces M, Alarcón-Forero LC. Paediatric cardiomyopathies: echocardiographic diagnosis, clinical profile, and demographic characteristics: the experience of a tertiary referral centre for Latin American paediatric cardiology. Cardiol Young [Internet]. 2020 Apr 17;30(4):462– Available from:https://www.cambridge.org/core/product/identifier/S1047951120000281/type/journal_article
    20. Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2019 Jul 2;140(1). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000682
    21. Yotti R, Seidman CE, Seidman JG. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies. Annu Rev Genomics Hum Genet [Internet]. 2019 Aug 31;20(1):129–53. Available from: https://www.annualreviews.org/doi/10.1146/annurev-genom-083118-015306
    22. Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation [Internet]. 2021 Jul 6;144(1):7–19. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.053033
    23. Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, Depalma S, et al. Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation. J Am Coll Cardiol [Internet]. 2010 Jan;55(4):320–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109709037784
    24. Xiao L, Li C, Sun Y, Chen Y, Wei H, Hu D, et al. Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy. Front Cardiovasc Med [Internet]. 2021 Apr 30;8. Available from: https://www.frontiersin.org/articles/10.3389/fcvm.2021.657689/full
    25. Liew C-C, Sole MJ, Yamauchi-Takihara K, Kellam B, Anderson DH, Lin L, et al. Complete sequence and organization of the human cardiac β-myosin heavy chain gene. Nucleic Acids Res [Internet]. 1990;18(12):3647–51. Available from: https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/18.12.3647
    26. Bang M-L, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The Complete Gene Sequence of Titin, Expression of an Unusual ≈700-kDa Titin Isoform, and Its Interaction With Obscurin Identify a Novel Z-Line to I-Band Linking System. Circ Res [Internet]. 2001 Nov 23;89(11):1065–72. Available from: https://www.ahajournals.org/doi/10.1161/hh2301.100981
    27. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci [Internet]. 1993 May;90(9):3993–7. Available from: https://pnas.org/doi/full/10.1073/pnas.90.9.3993
    28. Myosin, heavy chain 7, cardiac muscle, beta; MYH7 [Internet]. 2018. Available from: https://www.omim.org/entry/160760
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: 31 pp; application/pdf

  5. 5
  6. 6

    المؤلفون: Bardají Carrillo, Miguel

    المساهمون: Universidad de Valladolid. Servicio de Medios Audiovisuales y Nuevas Tecnologías

    وصف الملف: video/mp4

  7. 7

    المؤلفون: Bardají Carrillo, Miguel

    المساهمون: Universidad de Valladolid. Servicio de Medios Audiovisuales y Nuevas Tecnologías

    وصف الملف: video/mp4

  8. 8
    Dissertation/ Thesis
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11

    المساهمون: Fernández Sarmiento, Jaime, Barrera, Pedro

    المصدر: Moloney-Harmon PA. Pediatric sepsis: The infection unto death. Crit Care Nurs Clin North Am. 2005;17(4):417-429. doi:10.1016/j.ccell.2005.08.004.
    Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol 43. Springer Berlin Heidelberg; 2017. doi:10.1007/s00134-017-4683-6.
    Carcillo JA. Pediatric septic shock and multiple organ failure. Crit Care Clin. 2003;19:413-440.
    Fern??ndez Sarmiento J, Araque P, Yepes M, Mulett H, Tovar X, Rodriguez F. Correlation between Arterial Lactate and Central Venous Lactate in Children with Sepsis. Crit Care Res Pract. 2016;2016. doi:10.1155/2016/7839739.
    Ruth A, McCracken CE, Fortenberry JD, Hall M, Simon HK, Hebbar KB. Pediatric Severe Sepsis. Pediatr Crit Care Med. 2014;15(9):828-838. doi:10.1097/PCC.0000000000000254.
    Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60. doi:10.1007/s00134-007-0934-2.
    Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017. doi:10.1097/CCM.0000000000002425.
    Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201412-2323OC.
    Samaraweera SA, Gibbons B, Gour A, Sedgwick P. Arterial versus venous lactate: a measure of sepsis in children. Eur J Pediatr. 2017;176(8):1055-1060. doi:10.1007/s00431-017-2925-9.
    Okorie ON, Dellinger P. Lactate: Biomarker and Potential Therapeutic Target. Crit Care Clin. 2011;27(2):299-326. doi:10.1016/j.ccc.2010.12.013.
    Gutierreza G, Wulf-Gutierrezb M RD. Monitoring oxygen transport and tissue oxygenation. Curr Opin Anaesthesiol. 2004;17:107–117.
    M P. Hemodynamic monitoring in the intensive care unit. Clin Chest Med. 2003;24:549– 560.
    Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*. Pediatr Crit Care Med. 2005;6(1):2-8. doi:10.1097/01.PCC.0000149131.72248.E6.
    Vallée F, Vallet B, Mathe O, et al. Central venous-to-arterial carbon dioxide difference: An additional target for goal-directed therapy in septic shock? Intensive Care Med. 2008;34(12):2218-2225. doi:10.1007/s00134-008-1199-0.
    Durkin R, Gergits M, Reed J FJ. The relationship between the arteriovenous carbon dioxide gradient and cardiac index. J Crit Care. 1993;8:217-221.
    KM Ho, R Harding JC. A comparison of central venous-arterial and mixed venousarterial carbon dioxide tension gradient in circulatory failure. JAnaesth Intensive Care. 2007;35(5):695-701.
    Casserly B, Read R, Levy MM. Hemodynamic Monitoring in Sepsis. Crit Care Nurs Clin North Am. 2011;23(1):149-169. doi:10.1016/j.ccell.2010.12.009.
    Carcillo JA, Han K, Lin J, Orr R. Goal-Directed Management of Pediatric Shock in the Emergency Department. Clin Pediatr Emerg Med. 2007;8(3):165-175. doi:10.1016/j.cpem.2007.07.002.
    G M. The ancient riddle of sigma eta psi iota sigma (sepsis). J Infect Dis. 1991;163:937-945.
    Angus DC, van der Poll T. Severe Sepsis and Septic Shock. N Engl J Med. 2013;369(9):840-851. doi:10.1056/NEJMra1208623.
    Bone RC, Sibbald WJ SC. The ACCP-SCCM Consensus Conference on sepsis and organ failure. Chest. 1992;101:1481-1483.
    Levy MM, Fink MP, Marshall JC et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256.
    Jean, Louis V. Intensive Care Medicine Annual Update.; 2009.
    Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801. doi:10.1001/jama.2016.0287.
    Mallat J, Pepy F, Lemyze M, et al. Central venous-to-arterial carbon dioxide partial pressure difference in early resuscitation from septic shock. Eur J Anaesthesiol. 2014;31(7):371-380. doi:10.1097/EJA.0000000000000064.
    Tsolaki V, Makris D, Mantzarlis K. Review Article Sepsis-Induced Cardiomyopathy : Oxidative Implications in the. 2017;2017.
    Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natason C F, TM et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100(4):483–490.
    Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive Care. 2015;3(1):48. doi:10.1186/s40560-015-0112-5.
    Liu YC, Yu MM, Shou ST, Chai YF. Sepsis-induced cardiomyopathy: Mechanisms and treatments. Front Immunol. 2017;8(AUG):1-8. doi:10.3389/fimmu.2017.01021.
    Ospina-Tascón GA, Umaña M, Bermúdez WF, et al. Can venous-to-arterial carbon dioxide differences reflect microcirculatory alterations in patients with septic shock? Intensive Care Med. 2016;42(2):211-221. doi:10.1007/s00134-015-4133-2.
    Allen, Hugh D.; Driscoll, David J.; Shaddy, Robert E.; Feltes TF. Moss and Adam’s Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adults.; 2008.
    Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK A-H. Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease. J Coll Physicians Surg Pak. 2009;19(10):640-643.
    Chen Rongxin, Zhang Yucai, Cui Yun, Miao Huijie, Xu Liang RQ. Central venousto-arterial carbon dioxide difference in critically ill pediatric patients with septic shock. Chin J Pediatr. 2014;52(12):918-922.
    Ospina-Tascón GA, Bautista-Rincón DF, Umaña M, et al. Persistently high venousto-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care. 2013;17(6):R294. doi:10.1186/cc13160.
    Chua MT, Kuan W Sen. Venous-to-arterial carbon dioxide differences and the microcirculation in sepsis. Ann Transl Med. 2015;4(14):4-6. doi:10.3978/j.issn.23055839.2015.12.55.
    Ford H, Systems H, Re-CW. The Ne w E n g l a nd Jour n a l o f Me d ic i ne EARLY GOAL-DIRECTED THERAPY IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK. 2001;345(19):1368-1377.
    Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK, Anwar-ul-Haque. Venoarterial PCO2 difference: A marker of postoperative cardiac output in children with congenital heart disease. J Coll Physicians Surg Pakistan. 2009;19(10):640643. doi:10.2009/JCPSP.640643.
    Cuschieri J, Rivers E, Donnino M, Katilius M, Jacobsen G, Nguyen HB, Pamukov N HN. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med. 2005;31:818–822.
    Bakker J, Vincent JL, Gris P, Leon M, Goffernils M KR. Veno –arterial Carbon Dioxide Gradient in Human Septic SOC. Chest. 1992;101:509 – 15.
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  12. 12
    Dissertation/ Thesis
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    المساهمون: Fernández Sarmiento, Jaime

    المصدر: 1. Moloney-Harmon P. Pediatric Sepsis: The Infection unto Death. Crit Care Nurs Clin N Am 2005; 17: 417 – 429
    2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker M, Jaeschke R, Reinhart K, Angus DC, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36:296–327.
    3. Carcillo J. Pediatric septic shock and multiple organ failure. Crit Care Clin 2003; 19, 413– 440.
    4. Pediatric Advanced Life Support. Provider Manual. American Heart Association. 2006.
    5. Vincent JL. Intensive Care Medicine Annual Update. Springer. 2009.
    6. West J. B. Best y Taylor. Bases Fisiológicas de la Práctica Médica. 12da Edición. Editorial Médica Panamericana. 1991
    7. Gutierreza G, Wulf-Gutierrez M, Reines D. Monitoring oxygen transport and tissue oxygenation. Curr Opin Anaesthesiol 2004; 17:107–117.
    8. Pinsky M. Hemodynamic monitoring in the intensive care unit. Clin Chest Med 2003; 24, 549– 560.
    9. Goldstein B, Giroir B, Randolph A and the Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2–8.
    11. Durkin R, Gergits MA, Reed JF 3rd, Fitzgibbons J. The Relationship Between the Arteriovenous Carbon Dioxide Gradient and Cardiac Index. J Crit Care. 1993, 8(4):217-21
    12. Ho KM, Harding R, Chamberlain. A comparison of central venous-arterial and mixed venous-arterial carbon dioxide tension gradient in circulatory failure. J.Anaesth Intensive Care. 2007; (5):695-701.
    13. Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK, Anwar-ul-Haque. Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease. J Coll Physicians Surg Pak. 2009; 19(10):640-3.
    14. Carcillo J, Han K, Lin J, MD, Orr R. Goal-Directed Management of Pediatric Shock in the Emergency Department. Clin Ped Emerg Med 2007; (8)165-175.
    15. Ortegón L, Fernández J. Impacto de la antibioticoterapia empirica temprana en pacientes pediatricos con sepsis en la unidad de cuidado intensivo pediátrico de la Fundación Cardioinfantil. (Tesis de grado). Premio Arturo Aparicio al mejor trabajo de investigación. Universidad del Rosario; 2009.
    16. Cuschieri J, Rivers E, Donnino M, Katilius M, Jacobsen G, Nguyen HB, Pamukov N, Horst NM. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 2005; (31) 818–822.
    17. Bakker J, Vincent JL, Gris P, Leon M, Goffernils M, Kahn R. Veno –arterial Carbon Dioxide Gradient in Human Septic SOC. Chest 1992; (101) 509 – 15.
    18. Nichols, D. Roger's Textbook of Pediatric Intensive Care, 4th Edition. Lippincott Williams & Wilkins. 2008
    19. Troskot R, Šimurina T, Žižak M, Majstorović K, Marinac I, Mrakovčić-Šutić I. Prognostic Value of Venoarterial Carbon Dioxide Gradient in Patients with Severe Sepsis and Septic Shock. Croat Med J. 2010; 51(6):501-8
    20. Futiere E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE, Constantin JM, Vallet B. Central venous O2 saturation and venous-to arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery. Critical Care 2010; 14 (5):R193
    21. Silva JM, Ribas A, Lopes J, Ribeiro MH, Nacevicius C, Toledo D, Rezende E, Malbouisson L. A large Venous-Arterial PCO2 Is Associated with Poor Outcomes in Surgical Patients. Anesthesiol Res Pract. 2011;2011:759792
    22. Brierley J, Choong K, Cornell T, DeCaen A, Deymann A, Doctor A, Davis A, Duff J, et al. 2007 American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2009; 37:000–000
    23. Casserly B, Read R, Levy M. Hemodynamic Monitoring in Sepsis. Crit Care Clin 2009; 25 : 803–823
    24. Ruiz A, Morillo L. Epidemiología Clínica. Investigación Clínica Aplicada. Editorial Médica Panamericana. 2004
    25. Allen, Hugh D.; Driscoll, David J.; Shaddy, Robert E.; Feltes, Timothy F. Moss and Adam’s Heart Disease in Infants, Children and Adolescents: Including the fetus and Young Adults. 7th Ed. Lippincott Williams & Wilkins. 2008
    26. Rivers E, Guyen R, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy In The Treatment Of Severe Sepsis And Septic Shock. N Engl J Med 2001;345:1368-77
    27. Maddirala S, Khan A. Optimizing Hemodynamic Support in Septic Shock Using Centraland Mixed Venous Oxygen Saturation. Crit Care Clin 2010; 26: 323–333
    28. Rivers EP, Ander DS, Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001; 7(3):204-11
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  18. 18
    Academic Journal